Arabic Arabic English English French French German German
dark

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada’s National Research Council

Lexaria Bioscience Corp., a global innovator in drug delivery platforms is pleased to announce results from its antiviral drug molecular characterization study VIRAL-MC21-1 recently completed by Canada’s premier federally funded research organization, the National Research Council. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

Next Post

Vitrolife AB (publ) – Interim report January – June 2021: Good growth and acquisition of Igenomix

Related Posts
Total
0
Share